Cargando…

S110. THE CLINICAL IMPLICATION OF CLINICIAN-RATED DIMENSIONS OF PSYCHOSIS SYMPTOM SEVERITY (CRDPSS) FOR DIAGNOSIS BY DSM-5

BACKGROUND: The most recently published the 5th edition of the DSM proposed a dimensional approach with continuous of schizophrenia and other psychoses. The newly proposed Clinician-Rated Dimensions of Psychosis Symptom Severity (CRDPSS) in the DSM was recommended to be evaluated in all disorders wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nam, Beomwoo, Bahk, Won-Myong, Lee, Sang-Yeol, Lee, Kwanghun, Jon, Duk-In, Lim, Eunsung, Park, Sung-Yong, Song, Min-Kyu, Jo, Seongwoo, Jeon, Youngsoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887519/ http://dx.doi.org/10.1093/schbul/sby018.897

Ejemplares similares

F194. ASSOCIATION STUDY BETWEEN TREATMENT RESPONSE OF AMISULPRIDE AND DOPAMINE D3 RECEPTOR GENE POLYMORPHISMS
por: Lee, Kwanghun, et al.
Publicado: (2018)

T116. CAFFEINE-INDUCED PSYCHIATRIC MANIFESTATIONS
por: Lee, Kwanghun, et al.
Publicado: (2018)

F115. INSIGHT AND MANIC SYMPTOMS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA IN THE KOREAN COMMUNITY
por: Jon, Duk-In, et al.
Publicado: (2018)

S7. NEOSENSITIZATION TO MULTIPLE DRUGS FOLLOWING DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME (DRESS)
por: Kim, Moon Doo, et al.
Publicado: (2018)

T219. THE ROLE OF MELATONIN AND MELATONIN AGONISTS IN COUNTERACTING ANTIPSYCHOTIC-INDUCED METABOLIC SIDE EFFECTS: A SYSTEMATIC REVIEW
por: Bahk, Won-Myong, et al.
Publicado: (2018)

S220. BLONANSERIN AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA – WHO IS BENEFITED FROM BLONANSERIN AUGMENTATION? AN OPEN-LABEL, PROSPECTIVE, MULTI-CENTER STUDY
por: Bahk, Won-Myong, et al.
Publicado: (2018)

M95. DSM-5 CLINICIAN-RATED DIMENSIONS OF PSYCHOSIS SYMPTOM SEVERITY: PSYCHOMETRIC PROPERTIES
por: Liemburg, Edith, et al.
Publicado: (2020)

M46. THE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH SCHIZOPHRENIA
por: Jang, Seung-Ho, et al.
Publicado: (2020)

T230. DOSE TRENDS OF ARIPIPRAZOLE FROM 2004 TO 2014 IN PSYCHIATRIC INPATIENTS IN KOREA
por: Kwon, Young-Joon, et al.
Publicado: (2018)

S196. ASSOCIATION BETWEEN INTRACELLULAR INFECTIOUS AGENTS AND SCHIZOPHRENIA IN KOREA
por: Kwon, Young-Joon, et al.
Publicado: (2018)

M185. THE EFFECTS OF GROUP ARTS THERAPY BASED ON EMOTION MANAGEMENT TRAINING ON THE EMOTIONAL EXPRESSION, ALEXITHYMIA, DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA
por: Lim, Eunsung, et al.
Publicado: (2020)

F3. A CASE OF LEUKOCYTOSIS ASSOCIATED WITH CLOZAPINE TREATMENT FOR THE MANAGEMENT OF CHRONIC SCHIZOPHRENIA
por: Song, Min-Kyu, et al.
Publicado: (2018)

F213. THE EFFECTS OF GROUP INTEGRATIVE ARTS THERAPY BASED ON SOCIAL SKILL TRAINING ON THE SOCIAL ADAPTIVE FUNCTION, EMPOWERMENT AND SUBJECTIVE WELL-BEING IN INPATIENTS WITH CHRONIC SCHIZOPHRENIA
por: Lim, Eunsung, et al.
Publicado: (2018)

T251. THE STUDY OF QUALITY OF LIFE AND A GLOBAL FUNCTIONING FOR THE SCHIZOPHRENIA PATIENTS IN COMMUNITY BY THEIR RESIDENTIAL ENVIRONMENT
por: Lee, Sang-Yeol, et al.
Publicado: (2018)

M118. FACTOR STRUCTURE OF THE CLINICIAN-RATED DIMENSION OF PSYCHOSIS SYMPTOM SEVERITY IN PATIENTS WITH EARLY PSYCHOSIS
por: Lee, Kyuyoung, et al.
Publicado: (2020)

Factor Structure of the Clinician-Rated Dimensions of Psychosis Symptom Severity in Patients with Schizophrenia
por: Park, Seon-Cheol, et al.
Publicado: (2016)

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2019)

T77. ASSOCIATION BETWEEN INTRACELLULAR INFECTIOUS AGENTS AND SCHIZOPHRENIA
por: Kwon, Young-Joon, et al.
Publicado: (2020)

F45. THE EFFICACY AND SAFETY OF BLONASERIN AFTER SWITCHING FROM OTHER ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC INPATIENTS: AN OPEN-LABEL, MULTI-CENTER TRIAL
por: Yoon, Bo-Hyun, et al.
Publicado: (2018)

S216. CASE REPORT OF TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME IN CHILD ADOLESCENT
por: Doo Kim, Moon, et al.
Publicado: (2020)

Cannabis and Psychosis Through the Lens of DSM-5
por: Pearson, Nathan T., et al.
Publicado: (2019)

F223. COMPARATIVE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH CHRONIC SCHIZOPHRENIA AND HEALTHY CONTROL
por: Lee, Sang-Yeol, et al.
Publicado: (2018)

M110. PREDICTING RISK OF PSYCHOSIS IN A GENERAL POPULATION SAMPLE
por: Kounali, Daphne, et al.
Publicado: (2020)

Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study
por: Woo, Young Sup, et al.
Publicado: (2020)

The Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
por: Kim, Won, et al.
Publicado: (2011)

Neuroscience-based Nomenclature (NbN) for Clinical Psychopharmacology and Neuroscience
por: Uchida, Hiroyuki, et al.
Publicado: (2016)

Values and DSM-5: looking at the debate on attenuated psychosis syndrome
por: Gonçalves, Arthur Maciel Nunes, et al.
Publicado: (2016)

Screening with the Korean Version of the Mood Disorder Questionnaire for Bipolar Disorders in Adolescents: Korean Validity and Reliability Study
por: Shim, Se-Hoon, et al.
Publicado: (2018)

Clinical assessment of bipolar depression: validity, factor structure and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS)
por: Jung, Young-Eun, et al.
Publicado: (2016)

Affective dimension of early psychosis and suicidality
por: Durmaz, Onur
Publicado: (2018)

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea
por: Woo, Young Sup, et al.
Publicado: (2017)

T230. IDENTITY IN THE EARLY STAGES OF PSYCHOSIS: PERSPECTIVES OF CANADIAN EARLY PSYCHOSIS CLINICIANS
por: Ben-David, Shelly, et al.
Publicado: (2020)

Genome Sequences of Amycolatopsis orientalis subsp. orientalis Strains DSM 43388 and DSM 46075
por: Jeong, Haeyoung, et al.
Publicado: (2013)

Anticipating DSM-V: Should Psychosis Risk Become a Diagnostic Class?
por: Carpenter, William T.
Publicado: (2009)

Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis
por: Fusar-Poli, Paolo, et al.
Publicado: (2016)

9. DOES BIOLOGY READ THE DSM? TRANSDIAGNOSTIC FINDINGS IN PSYCHOSIS AND IMPLICATIONS FOR TREATMENT
por: Owen, Michael
Publicado: (2018)

T75. METABOLIC SYNDROME AND HEAR RATE VARIABILITY IN SCHIZOPHRENIC INPATIENTS
por: Yoon, Bo-Hyun, et al.
Publicado: (2020)

Cerebral white matter structure is associated with DSM-5 schizophrenia symptom dimensions
por: Viher, Petra V., et al.
Publicado: (2016)

Validation of the Danish PTSD Checklist for DSM-5 in trauma-exposed chronic pain patients using the Clinician-Administered PTSD Scale for DSM-5
por: Hansen, Maj, et al.
Publicado: (2023)

DSM-5 posttraumatic stress symptom dimensions and health-related quality of life among Chinese earthquake survivors
por: Li, Gen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vb4p8bumco0sjgbvjqekqat92b